APOB and metabolic dysfunction-associated steatotic liver disease: Conversely, increased ApoB secretion [28–30] and decreased ApoB clearance [31] due to insulin resistance can lead to elevated ApoB levels in the blood and promote the occurrence and development of NAFLD.